These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 2197591)

  • 41. Investigation of the role of the ras protooncogene point mutation in human uveal melanomas.
    Soparker CN; O'Brien JM; Albert DM
    Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2203-9. PubMed ID: 8505202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Presence of mutations in all three ras genes in human thyroid tumors.
    Suarez HG; du Villard JA; Severino M; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
    Oncogene; 1990 Apr; 5(4):565-70. PubMed ID: 2183158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Detection of point mutations of C-Ki-ras oncogene in colon cancer by PCR using specific oligonucleotide probes].
    Xu KM
    Zhonghua Zhong Liu Za Zhi; 1992 Jul; 14(4):261-3. PubMed ID: 1396073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of RAS oncogene mutation in head and neck carcinomas.
    Anderson JA; Irish JC; Ngan BY
    J Otolaryngol; 1992 Oct; 21(5):321-6. PubMed ID: 1361585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Point mutation of c-Ha-ras oncogene in oral cancers].
    Liu XF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1991 Nov; 26(6):326-8, 388. PubMed ID: 1820236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique.
    Levi S; Urbano-Ispizua A; Gill R; Thomas DM; Gilbertson J; Foster C; Marshall CJ
    Cancer Res; 1991 Jul; 51(13):3497-502. PubMed ID: 1675933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of mutation of a synthetic c-Ha-ras gene containing hypoxanthine.
    Kamiya H; Miura H; Kato H; Nishimura S; Ohtsuka E
    Cancer Res; 1992 Apr; 52(7):1836-9. PubMed ID: 1551113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism.
    Yoshimoto K; Iwahana H; Fukuda A; Sano T; Saito S; Itakura M
    Cancer Res; 1992 Sep; 52(18):5061-4. PubMed ID: 1516062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products.
    Meltzer SJ; Mane SM; Wood PK; Resau JH; Newkirk C; Terzakis JA; Korelitz BI; Weinstein WM; Needleman SW
    Cancer Res; 1990 Jun; 50(12):3627-30. PubMed ID: 2187599
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung.
    Rodenhuis S; van de Wetering ML; Mooi WJ; Evers SG; van Zandwijk N; Bos JL
    N Engl J Med; 1987 Oct; 317(15):929-35. PubMed ID: 3041218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amplification of the N-myc oncogene in an adenocarcinoma cell line of the lung.
    Kashii T; Mizushima Y; Nakagawa K; Monno S; Yano S
    Anticancer Res; 1992; 12(3):621-4. PubMed ID: 1622116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical significance of ras oncogene activation in human lung cancer.
    Rodenhuis S; Slebos RJ
    Cancer Res; 1992 May; 52(9 Suppl):2665s-2669s. PubMed ID: 1562997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activated ras alleles in human carcinoma of the prostate are rare.
    Gumerlock PH; Poonamallee UR; Meyers FJ; deVere White RW
    Cancer Res; 1991 Mar; 51(6):1632-7. PubMed ID: 1998954
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of mutations at codon 61 of the Ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis.
    Dragani TA; Manenti G; Colombo BM; Falvella FS; Gariboldi M; Pierotti MA; Della Porta G
    Oncogene; 1991 Feb; 6(2):333-8. PubMed ID: 2000226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isochromosome 12p in non-seminoma cell lines: karyologic amplification of c-ki-ras2 without point-mutational activation.
    Dmitrovsky E; Murty VV; Moy D; Miller WH; Nanus D; Albino AP; Samaniego F; Bosl G; Chaganti RS
    Oncogene; 1990 Apr; 5(4):543-8. PubMed ID: 2183156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Harvey ras 1 gene is activated in papillomavirus-associated carcinomas of the upper alimentary canal in cattle.
    Campo MS; McCaffery RE; Doherty I; Kennedy IM; Jarrett WF
    Oncogene; 1990 Mar; 5(3):303-8. PubMed ID: 2156207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers.
    Moley JF; Brother MB; Wells SA; Spengler BA; Biedler JL; Brodeur GM
    Cancer Res; 1991 Mar; 51(6):1596-9. PubMed ID: 1998949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
    Kitada H; Tsutsumi M; Tsujiuchi T; Takahama M; Fukuda T; Narita N; Konsihi Y
    Mol Carcinog; 1996 Apr; 15(4):276-83. PubMed ID: 8634086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nucleotide sequence of canine c-N-ras: codons 1 to 71.
    Saunders KA; Madewell BR; Oreffo VI; Kraegel SA; Gumerlock PH
    Am J Vet Res; 1992 Apr; 53(4):600-3. PubMed ID: 1586036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism.
    Yoshimoto K; Iwahana H; Fukuda A; Sano T; Katsuragi K; Kinoshita M; Saito S; Itakura M
    Jpn J Cancer Res; 1992 Oct; 83(10):1057-62. PubMed ID: 1452458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.